The Next Generation in Bilevel Therapy Now Available on ResMed's Award-Winning S9(TM) Platform

Oslo, Norway (ots/PRNewswire) - ResMed , a leading
developer, manufacturer, and distributor of sleep and respiratory
medical equipment, announced the launch of its next generation
bilevel therapy devices.

"We are proud to announce the launch of the bilevel range of
products on the S9(TM) platform, our latest and most innovative flow
generator system for treating respiratory disorders including
sleep-disordered breathing (SDB). Now, for the first time in our
history, patients have one platform that can treat obstructive sleep
apnea, central sleep apnea and Cheyne-Stokes respiration as well as
provide noninvasive ventilation (NIV) for patients requiring
ventilatory support," said Michael Farrell, SVP of the Global Sleep
Business Unit at ResMed. "Our goal is to increase patients' quality
of life by providing comfortable, quiet, easy-to-use, and highly
effective treatment. A critical element of successful treatment is
long-term adherence to therapy. Since its launch just over a year
ago, the S9 Series has been able to help physicians and respiratory
therapists achieve that goal - driving therapeutic compliance by
patients around the globe."

Historically, patients' ability to comply with sleep or
respiratory therapies was negatively affected by noisy devices, nasal
dryness/congestion and breathing discomfort. To combat these negative
effects and increase patients' ability to adhere to respiratory
therapy, ResMed's next generation bilevel devices build on features
that are crucial to maintaining and increasing overall patient
compliance.

ResMed's enhanced Easy-Breathe(TM) motor technology reduces noise
transferred through the mask to the patient by 78%, compared to the
S8(TM) Series II. The improved ClimateControl(TM) system ensures
consistent therapeutic air temperature and humidification, working to
prevent rain-out and dryness, independent of external ambient
conditions. With the integration of ResMed's Vsync(TM),
TiControl(TM), and Easy-Breath waveform technologies, each device can
now be fine-tuned to synchronise to the specific needs of each
individual patient. Finally, patient data can now be accessed via the
easy-to-use color screen or can be downloaded in high resolution and
viewed in ResMed's ResScan(TM) software.

"We remain focused on providing best in class NIV solutions; now
delivering NIV therapy by way of a smaller, lighter, and quieter
platform. The VPAP ST offers unmatched therapy performance to a
broader range of patients through the enhancements of our clinically
proven synchronisation algorithms, Vsync and TiControl alongside
Climate Control and a higher backup rate," said Geoff Neilson, Vice
President - Ventilation Strategic Business Unit.

ResMed's new pressure support bilevel devices include the
VPAP(TM) S, a bilevel pressure support therapy device; the Auto 25,
an auto-adjusting bilevel therapy device; the AutoSet CS(TM), the
adaptive servo-ventilation therapy device; and the VPAP(TM) ST, a
noninvasive pressure support ventilator. All four devices are built
to meet the highest standard of effective therapy, comfortable
treatment, and ease of use.

For additional product information visit http://www.resmed.com

About ResMed

ResMed is a leading developer, manufacturer, and distributor of
medical equipment for treating, diagnosing, and managing
sleep-disordered breathing and other respiratory disorders. We are
dedicated to developing innovative products to improve the lives of
those who suffer from these conditions and to increasing awareness
among patients and healthcare professionals of the potentially
serious health consequences of untreated sleep-disordered breathing.
For more information on ResMed, visit http://www.resmed.com

Contact ResMed:
Henrik Aase
Marketing Communications Director - Europe
Office: +47-67-11-88-59 | Mobile: +47-97-53-91-12
henrik.aase@resmed.com
For interviews, photos, additional info:
Rikke Eckhoff, Burson-Marsteller Oslo
Mobile : +47-990-82-202
rikke.eckhoff@bm.com

ots Originaltext: ResMed
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Contact ResMed: Henrik Aase, Marketing Communications Director
-Europe, Office: +47-67-11-88-59 | Mobile:
+47-97-53-91-12,henrik.aase@resmed.com; For interviews, photos,
additional info: RikkeEckhoff, Burson-Marsteller Oslo, Mobile :
+47-990-82-202,rikke.eckhoff@bm.com